直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Ad Law Buzz Blog

“#1” Claims: NAD’s Guardrails on Defining Product Categories

February 27, 2026

Authored and Edited by Jennifer E. Fried

Advertising claims such as “#1 floor wax” or “#1 convection oven” may sound straightforward. But these “#1” claims often beg the question: “#1 among whom?” What counts as floor wax? And what makes a convection oven a convection oven? Answering such definitional questions may require advertisers to delineate market categories based on fine distinctions.

In a recent Fast-Track SWIFT decision, NAD grappled with category definitions as it evaluated UdiSense, Inc.’s claims to offer the “#1 baby monitor” and the “#1 smart baby monitor.” The dispute turned on the meaning of “baby monitor”—and whether UdiSense had properly excluded a competitor’s product from the category when describing itself as “#1.”

This was not the first time NAD has weighed in on these issues. Past cases have hinged on the definition of categories such as “nail anti-fungals” and “topical pain relievers.” Similarly, NAD has wrestled with automakers’ “Best in Class” claims that rest on how a “class” of automobiles is defined. Here, NAD’s take was unsurprising: where ambiguity exists, NAD will construe the product category broadly.

Key Takeaways

    • Avoid Defining a Category Creatively: NAD requires advertisers to substantiate “all reasonable interpretations” of any given claim.
    • Qualify “#1” Claims To Avoid Ambiguity: Had Nanit qualified the claim (e.g. "#1 Smart Video Monitor"), the outcome would likely have been different.
    • Bring Receipts: Show examples of marketplace usage, regulatory definitions, and other third-party evidence.

 

The Challenge

Owlet, Inc. challenged claims made by UdiSense, Inc., the maker of Nanit video baby monitors. UdiSense claimed that its product was the “#1 smart baby monitor” and the “#1 baby monitor.” Owlet disagreed, noting that its own wearable device outsells Nanit by a wide margin. UdiSense maintained that its “#1” claims were accurate because the two companies sell fundamentally different products; Nanit sells a video monitor, whereas Owlet’s Dream Sock is a wearable device that tracks heart rate and oxygen levels and has no video component.

NAD’s Decision: No Gerrymandering the Market

NAD rejected Nanit’s narrow market definition, reiterating that a product class must be defined consistently with consumers’ reasonable understanding. NAD found that the term “monitor” is broad enough to encompass wearable devices, noting that the competing wearable product was marketed as a “monitor.”

Here, NAD emphasized that the Owlet Dream Sock is sold as a “monitor,” functions as a monitor by tracking real-time health data and is marketed to caregivers for the same purpose: monitoring an infant’s well-being. Because Nanit’s advertising did not expressly limit its “#1” claims to video monitors, NAD found, consumers would reasonably interpret the phrase “#1 smart baby monitor” to include top-selling smart devices such as the Dream Sock. Given that Owlet’s sales data—including sales of the Dream Sock—showed it leading the broader category, NAD recommended that Nanit discontinue the unqualified “#1” claims. This decision is a useful reminder that, when making “#1” claims, advertisers should be sure to rely on clearly defined product categories.

Tags

National Advertising Division (NAD), comparative advertising

Related Industries

Consumer Goods and Services

Consumer Products

Contacts

Jennifer E. Fried
Partner
Washington, DC
+1 202 408 4166
Email

Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP